211 related articles for article (PubMed ID: 22266197)
1. SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.
Mengeling BJ; Goodson ML; Bourguet W; Privalsky ML
Mol Cell Endocrinol; 2012 Apr; 351(2):306-16. PubMed ID: 22266197
[TBL] [Abstract][Full Text] [Related]
2. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.
Jonas BA; Varlakhanova N; Hayakawa F; Goodson M; Privalsky ML
Mol Endocrinol; 2007 Aug; 21(8):1924-39. PubMed ID: 17519355
[TBL] [Abstract][Full Text] [Related]
3. Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression.
Farboud B; Hauksdottir H; Wu Y; Privalsky ML
Mol Cell Biol; 2003 Apr; 23(8):2844-58. PubMed ID: 12665583
[TBL] [Abstract][Full Text] [Related]
4. Corepressor diversification by alternative mRNA splicing is species specific.
Privalsky ML; Snyder CA; Goodson ML
BMC Evol Biol; 2016 Oct; 16(1):221. PubMed ID: 27756201
[TBL] [Abstract][Full Text] [Related]
5. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
Li H; Leo C; Schroen DJ; Chen JD
Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
[TBL] [Abstract][Full Text] [Related]
6. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors.
Wong CW; Privalsky ML
Mol Cell Biol; 1998 Oct; 18(10):5724-33. PubMed ID: 9742089
[TBL] [Abstract][Full Text] [Related]
8. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.
Ghisletti S; Huang W; Jepsen K; Benner C; Hardiman G; Rosenfeld MG; Glass CK
Genes Dev; 2009 Mar; 23(6):681-93. PubMed ID: 19299558
[TBL] [Abstract][Full Text] [Related]
9. Synthetic retinoids dissociate coactivator binding from corepressor release.
Zechel C
J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
[TBL] [Abstract][Full Text] [Related]
10. Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants.
Mengeling BJ; Phan TQ; Goodson ML; Privalsky ML
J Biol Chem; 2011 Feb; 286(6):4236-47. PubMed ID: 21131350
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR.
Baniahmad A; Dressel U; Renkawitz R
Mol Endocrinol; 1998 Apr; 12(4):504-12. PubMed ID: 9544986
[TBL] [Abstract][Full Text] [Related]
12. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
[TBL] [Abstract][Full Text] [Related]
13. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Hong SH; David G; Wong CW; Dejean A; Privalsky ML
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
[TBL] [Abstract][Full Text] [Related]
14. The nuclear corepressors recognize distinct nuclear receptor complexes.
Cohen RN; Putney A; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
[TBL] [Abstract][Full Text] [Related]
15. Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals.
Privalsky ML; Goodson ML
BMC Res Notes; 2019 Jun; 12(1):343. PubMed ID: 31208445
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain.
Varlakhanova N; Snyder C; Jose S; Hahm JB; Privalsky ML
Mol Cell Biol; 2010 Mar; 30(6):1434-45. PubMed ID: 20065040
[TBL] [Abstract][Full Text] [Related]
17. Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.
Snyder CA; Goodson ML; Schroeder AC; Privalsky ML
Mol Cell Endocrinol; 2015 Sep; 413():228-35. PubMed ID: 26166430
[TBL] [Abstract][Full Text] [Related]
18. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
19. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
[TBL] [Abstract][Full Text] [Related]
20. Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.
Goodson ML; Jonas BA; Privalsky ML
J Biol Chem; 2005 Mar; 280(9):7493-503. PubMed ID: 15632172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
